EUVIMEDEUVIMED entdecken
Multizentrische Studie

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies

Mark Jansen, Remco de Brouwer, Fahima Hassanzada, Angela E Schoemaker, Amand F Schmidt, Maria D Kooijman-Reumerman, Valentina Bracun, Martijn G Slieker, Dennis Dooijes, Alexa M C Vermeer, Arthur A M Wilde, Ahmad S Amin und 8 weitere

JACC: Heart Failure · 2024

DOI: 10.1016/j.jchf.2023.07.007 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Mark Jansen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Cardiology, University Medical…. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies, Cardiomyopathy, Hypertrophic, Cardiomyopathy, Dilated. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Nederlandse Hartstichting, NIHR University College London Hospitals Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: MYH7 variants cause hypertrophic cardiomyopathy (HCM), noncompaction cardiomyopathy (NCCM), and dilated cardiomyopathy (DCM). Screening of relatives of patients with genetic cardiomyopathy is recommended from 10 to 12 years of age onward, irrespective of the affected gene. OBJECTIVES: This study sought to study the penetrance and prognosis of MYH7 variant-associated cardiomyopathies. METHODS: In this multicenter cohort study, penetrance and major cardiomyopathy-related events (MCEs) were assessed in carriers of (likely) pathogenic MYH7 variants by using Kaplan-Meier curves and log-rank tests. Prognostic factors were evaluated using Cox regression with time-dependent coefficients. RESULTS: In total, 581 subjects (30.1% index patients, 48.4% male, median age 37.0 years [IQR: 19.5-50.2 years]) were included. HCM was diagnosed in 226 subjects, NCCM in 70, and DCM in 55. Early penetrance and MCEs (age

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiomyopathiesCardiomyopathy, HypertrophicCardiomyopathy, DilatedHumansMaleAdultChild, PreschoolChildFemalePenetranceCohort StudiesPrognosisMutationMyosin Heavy ChainsCardiac Myosins

Stichwörter der Autor:innen

MYH7cardiomyopathymyosinpenetranceprognosisscreening

Substanzen

MYH7 protein, humanMyosin Heavy ChainsCardiac Myosins

Autor:innen und Institutionen

  • Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Cardiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Netherl…
  • Netherlands Heart Institute, Utrecht, the Netherlands; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart).
  • Department of Cardiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart); Institu…
  • Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.
  • European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart); Department of Pediatric Cardiology, University Medical Centre Utrecht, Utrecht University, the Netherlands.

Förderung

  • Nederlandse Hartstichting
  • NIHR University College London Hospitals Biomedical Research Centre

Zitieren

APA

Jansen, M., de Brouwer, R., Hassanzada, F., Schoemaker, A. E., Schmidt, A. F., Kooijman-Reumerman, M. D., Bracun, V., Slieker, M. G., Dooijes, D., Vermeer, A. M. C., Wilde, A. A. M., Amin, A. S., Lekanne Deprez, R. H., Herkert, J. C., Christiaans, I., de Boer, R. A., Jongbloed, J. D. H., van Tintelen, J. P., Asselbergs, F. W., & Baas, A. F. (2024). Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.07.007

Vancouver

Jansen M, de Brouwer R, Hassanzada F, Schoemaker AE, Schmidt AF, Kooijman-Reumerman MD, et al. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2023.07.007

BibTeX
@article{Jansen2024,
  author = {Jansen, Mark and de Brouwer, Remco and Hassanzada, Fahima and Schoemaker, Angela E and Schmidt, Amand F and Kooijman-Reumerman, Maria D and Bracun, Valentina and Slieker, Martijn G and Dooijes, Dennis and Vermeer, Alexa M C and Wilde, Arthur A M and Amin, Ahmad S and Lekanne Deprez, Ronald H and Herkert, Johanna C and Christiaans, Imke and de Boer, Rudolf A and Jongbloed, Jan D H and van Tintelen, J Peter and Asselbergs, Folkert W and Baas, Annette F},
  title = {Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies},
  journal = {JACC: Heart Failure},
  year = {2024},
  doi = {10.1016/j.jchf.2023.07.007}
}
Kostenlos starten →